🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

55,55 USD

Máx. histórico

108,06

1032 días

Split 1:6 del 25/06/2013

Caída desde máximo

-48,59%

Rango 52 semanas

54,16 – 88,31

Variación hoy

-12,66%

Cierre anterior

63,60

Rango de hoy

54,16 – 60,84

Volumen hoy

6.774.495

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,41%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 18 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/04/2020 13,85 14,19 13,28 13,55 -2,38% 6,57% 964.200
13/04/2020 14,06 14,20 13,45 13,88 -0,07% 5,33% 667.200
09/04/2020 14,71 14,85 13,68 13,89 +8,86% 7,95% 1.227.600
08/04/2020 12,33 12,92 12,19 12,76 +5,02% 5,92% 714.400
07/04/2020 12,67 12,82 11,95 12,15 -2,49% 6,87% 733.700
06/04/2020 12,37 12,66 11,93 12,46 +4,18% 5,90% 546.100
03/04/2020 11,98 12,24 11,45 11,96 -0,75% 6,59% 660.100
02/04/2020 11,07 12,17 10,75 12,05 +8,07% 12,83% 559.200
01/04/2020 11,18 11,85 11,10 11,15 -5,43% 6,71% 632.700
31/03/2020 12,73 12,81 11,50 11,79 -7,82% 10,29% 895.600
30/03/2020 11,90 13,36 11,37 12,79 +8,85% 16,72% 1.484.800
27/03/2020 10,99 12,30 10,89 11,75 +2,80% 12,83% 606.400
26/03/2020 10,48 12,24 10,48 11,43 +10,22% 16,79% 631.400
25/03/2020 10,77 11,35 10,13 10,37 -3,71% 11,33% 921.600
24/03/2020 10,32 11,07 10,10 10,77 +8,90% 9,40% 748.100
23/03/2020 9,70 10,41 9,44 9,89 +3,56% 10,00% 590.700
20/03/2020 9,08 10,75 8,75 9,55 +6,11% 22,03% 998.900
19/03/2020 8,70 9,90 8,54 9,00 +2,86% 15,63% 1.255.200
18/03/2020 9,97 10,40 8,00 8,75 -18,07% 24,07% 1.395.400
17/03/2020 9,96 10,68 8,73 10,68 +8,32% 19,58% 1.428.900
16/03/2020 8,86 9,93 8,68 9,86 -7,68% 14,11% 1.404.000
13/03/2020 10,73 10,73 9,07 10,68 +2,30% 15,47% 885.200
12/03/2020 11,75 11,82 10,27 10,44 -13,22% 13,19% 855.900
11/03/2020 13,02 13,23 12,03 12,03 -9,68% 9,22% 644.500
10/03/2020 13,71 13,93 12,13 13,32 +0,00% 13,13% 1.008.000
09/03/2020 13,61 14,80 13,29 13,32 -7,50% 11,09% 778.900
06/03/2020 14,78 15,14 13,60 14,40 -5,01% 10,42% 897.600
05/03/2020 14,54 15,36 14,19 15,16 +2,02% 8,05% 1.022.600
04/03/2020 14,80 16,15 13,63 14,86 +1,99% 17,03% 1.067.100
03/03/2020 14,19 15,25 14,19 14,57 +2,32% 7,47% 667.600